https://www.healthindustrywatch.com/article/905468413-my-esa-therapist-simplifies-the-process-to-get-an-online-esa-letter-in-2026 Health Industry Watch en PressRelease 2026-04-13T11:31:46+00:00 My ESA Therapist Simplifies the Process to Get an Online ESA Letter in 2026 https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24831237-my-esa-therapist-cover-photo-1537x807.jpeg https://www.healthindustrywatch.com/article/904514680-customising-ai-voice-models-to-meet-regional-needs Health Industry Watch en PressRelease 2026-04-13T11:30:00+00:00 Customising AI voice models to meet regional needs https://www.healthindustrywatch.com/article/904984928-applications-open-for-dnda26-awards-celebrating-humanity-centered-design-for-societal-impact-and-global-well-being Health Industry Watch en PressRelease 2026-04-13T11:00:00+00:00 Applications Open for DNDA26 Awards: Celebrating Humanity-Centered Design for Societal Impact and Global Well-Being https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24830562-dnda25-laureates-3240x2160.jpeg https://www.healthindustrywatch.com/article/905173878-digitalxforce-named-winner-of-2026-global-infosec-awards-for-its-ai-powered-continuous-control-assurance-cca Health Industry Watch en PressRelease 2026-04-13T11:00:00+00:00 DigitalXForce Named Winner of 2026 Global InfoSec Awards for its AI Powered Continuous Control Assurance (CCA) https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/19374840-digitalxforce-logo-1-3000x3000.png https://www.healthindustrywatch.com/article/905318087-invisible-disabilities-association-issues-call-for-participants-to-join-invisible-disabilities-walk-roll-in-may-2026 Health Industry Watch en PressRelease 2026-04-13T11:00:00+00:00 Invisible Disabilities Association Issues Call for Participants to Join Invisible Disabilities Walk & Roll in May 2026 https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24830876-2026-walk-and-roll-1920x1080.png https://www.healthindustrywatch.com/article/905461335-sa-l-k-turizminde-yeni-d-nem-b-y-me-s-r-yor-mevzuat-bask-s-art-yor Health Industry Watch en PressRelease 2026-04-13T10:25:06+00:00 Sağlık Turizminde Yeni Dönem: Büyüme Sürüyor, Mevzuat Baskısı Artıyor https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24831206-g-khan-g-ne-3064x1723.jpeg https://www.healthindustrywatch.com/article/905459200-investment-in-national-bio-convergence-program-surges Health Industry Watch en PressRelease 2026-04-13T10:03:25+00:00 Investment in National Bio-Convergence Program Surges https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24811468-dror-bin-ceo-of-the-israel-inn-2653x2653.jpeg https://www.healthindustrywatch.com/article/905451568-dr-bar-keklik-calls-for-greater-transparency-as-uk-patients-explore-breast-surgery-abroad Health Industry Watch en PressRelease 2026-04-13T09:59:06+00:00 Dr Barış Keklik Calls for Greater Transparency as UK Patients Explore Breast Surgery Abroad https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24831171-dr-bar-keklik-2204x1239.jpeg https://www.healthindustrywatch.com/article/905457770-south-korea-bioactive-sphingolipid-market-outlook-ceramide-led-growth-accelerates-as-doosan-corporation Health Industry Watch en PressRelease 2026-04-13T09:53:12+00:00 South Korea Bioactive Sphingolipid Market Outlook: Ceramide-Led Growth Accelerates as Doosan Corporation https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24831193-south-korea-bioactive-sphingoli-650x343.jpeg https://www.healthindustrywatch.com/article/904867247-four-core-product-matrices-of-feline-primary-cells-cloud-clone-empowers-new-breakthroughs-in-animal-research Health Industry Watch en PressRelease 2026-04-13T09:28:06+00:00 ‌Four Core Product Matrices of Feline Primary Cells: Cloud-Clone Empowers New Breakthroughs in Animal Research https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24830072-wuhan-cloud-clone-s-core-produc-961x719.png https://www.healthindustrywatch.com/article/904360172-happier-at-home-expands-to-fort-lauderdale-with-new-in-home-care-franchise Health Industry Watch en PressRelease 2026-04-13T09:00:00+00:00 Happier At Home Expands to Fort Lauderdale with New In-Home Care Franchise https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24827948-senior-care-at-home-in-ft-laude-1474x635.jpeg https://www.healthindustrywatch.com/article/904956541-mkh-capital-partners-acquires-haven-health-management-bringing-growth-capital-to-22-treatment-locations-across-the-u-s Health Industry Watch en PressRelease 2026-04-13T09:00:00+00:00 MKH Capital Partners Acquires Haven Health Management, Bringing Growth Capital to 22 Treatment Locations Across the U.S. https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24830430-icfr-bloomington-exterior-1500x1000.jpeg https://www.healthindustrywatch.com/article/904529816-charter-oak-state-college-offers-virtual-healthcare-open-house-may-13 Health Industry Watch en PressRelease 2026-04-13T08:30:00+00:00 Charter Oak State College Offers Virtual Healthcare Open House May 13 https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24805937-charter-oak-state-college-logo-1475x518.png https://www.healthindustrywatch.com/article/905017508-industry-highlight-satpro-setting-a-new-standard-for-clinician-safety-in-interventional-radiology-and-cardiology Health Industry Watch en PressRelease 2026-04-13T06:55:53+00:00 Industry Highlight: SATPRO – Setting a New Standard for Clinician Safety in Interventional Radiology and Cardiology https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24830639-satpro-product-980x1640.png https://www.healthindustrywatch.com/article/905432255-top-high-speed-handpiece-manufacturers-driving-a-new-standard-in-dental-equipment Health Industry Watch en PressRelease 2026-04-13T06:40:32+00:00 Top High Speed Handpiece Manufacturers Driving a New Standard in Dental Equipment https://www.healthindustrywatch.com/article/905433468-top-desiccant-manufacturers-driving-change-in-global-moisture-control-markets Health Industry Watch en PressRelease 2026-04-13T06:38:11+00:00 Top Desiccant Manufacturers Driving Change in Global Moisture Control Markets https://www.healthindustrywatch.com/article/905402725-sunway-medical-centre-penang-recognized-as-emerging-tertiary-medical-hub-malaysia-by-global-brand-frontier-awards-2025 Health Industry Watch en PressRelease 2026-04-13T05:38:09+00:00 Sunway Medical Centre Penang Recognized as Emerging Tertiary Medical Hub – Malaysia by Global Brand Frontier Awards 2025 https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24830973-sunway-medical-main-3750x1969.jpeg https://www.healthindustrywatch.com/article/905401871-vietnam-s-vinmec-elevates-high-tech-healthcare-standards-in-asia-with-robotics-and-next-gen-diagnostics Health Industry Watch en PressRelease 2026-04-13T05:37:06+00:00 Vietnam's Vinmec Elevates High-Tech Healthcare Standards in Asia with Robotics and Next-Gen Diagnostics https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24830976-vinmec-medtour4-1200x628.png https://www.healthindustrywatch.com/article/905423805-cervical-cancer-treatment-market-to-reach-us-14-6-bn-by-2033-says-persistence-market-research Health Industry Watch en PressRelease 2026-04-13T05:33:46+00:00 Cervical Cancer Treatment Market to Reach US$14.6 bn by 2033 Says Persistence Market Research https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24831015-cervical-cancer-treatment-marke-1040x720.png https://www.healthindustrywatch.com/article/904870611-jeio-tech-celebrates-10-year-partnership-with-seeding-labs-to-advance-global-scientific-research Health Industry Watch en PressRelease 2026-04-13T05:32:31+00:00 Jeio Tech Celebrates 10-Year Partnership with Seeding Labs to Advance Global Scientific Research https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/23927274-jeio-tech-global-network-1110x551.jpeg https://www.healthindustrywatch.com/article/905361959-fitness2020-opens-in-east-lake-bringing-premium-fitness-to-one-of-atlanta-s-most-storied-communities Health Industry Watch en PressRelease 2026-04-13T05:11:31+00:00 Fitness2020 Opens in East Lake, Bringing Premium Fitness to One of Atlanta's Most Storied Communities https://www.healthindustrywatch.com/article/904957129-boxlogix-parcel-named-mushiny-s-integrator-of-the-year Health Industry Watch en PressRelease 2026-04-13T00:00:00+00:00 BoxLogix Parcel Named Mushiny’s Integrator of the Year https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24830433-mushiny-integrator-of-the-year-3450x3512.jpeg https://www.healthindustrywatch.com/article/905144901-crestron-recognizes-the-promedia-group-among-top-10-fastest-growing-dealers-nationally Health Industry Watch en PressRelease 2026-04-13T00:00:00+00:00 Crestron Recognizes The ProMedia Group Among Top 10 Fastest Growing Dealers Nationally https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24830746-the-promedia-group-of-tampa-4096x2337.png https://www.healthindustrywatch.com/article/905470717-allogene-therapeutics-reports-interim-futility-analysis-from-pivotal-alpha3-trial-showing-58-3-mrd-clearance-with-cemacabtagene-ansegedleucel Health Industry Watch en PressRelease 2026-04-13T11:30:00+00:00 Allogene Therapeutics Reports Interim Futility Analysis from Pivotal ALPHA3 Trial Showing 58.3% MRD Clearance with Cemacabtagene Ansegedleucel (Cema-Cel) vs. 16.7% in Observation Arm in First-Line Consolidation LBCL https://ml.globenewswire.com/media/87e8712c-0741-409f-9942-c91b31e7c5e1/small/allogene-png.png https://www.healthindustrywatch.com/article/905470753-vireo-growth-announces-california-retail-joint-venture-with-glass-house-brands Health Industry Watch en PressRelease 2026-04-13T11:30:00+00:00 Vireo Growth Announces California Retail Joint Venture with Glass House Brands https://ml.globenewswire.com/media/d01c0dca-8260-48c8-8ead-e09111cf57b5/small/vireo-horizontalllogolockup-01-png.png https://www.healthindustrywatch.com/article/905470768-newly-published-u-s-expert-consensus-aligns-with-mediwound-s-strategy-for-chronic-wound-debridement Health Industry Watch en PressRelease 2026-04-13T11:30:00+00:00 Newly Published U.S. Expert Consensus Aligns with MediWound’s Strategy for Chronic Wound Debridement https://ml.globenewswire.com/media/55509183-b8b9-4da4-ae63-92c83760b5d9/small/mdwd-logo-jpg.jpg https://www.healthindustrywatch.com/article/905470778-northstrive-biosciences-announces-u-s-arrival-of-el-32-working-cell-bank-and-initiation-of-manufacturing-optimization-for-dual-myostatin-assets Health Industry Watch en PressRelease 2026-04-13T11:30:00+00:00 NorthStrive Biosciences Announces U.S. Arrival of EL-32 Working Cell Bank and Initiation of Manufacturing Optimization for Dual Myostatin Assets Targeting Muscle Preservation with GLP-1 Therapies in Collaboration with Modulant Biosciences https://ml.globenewswire.com/media/b1dabc1a-ea7b-49d8-a9cd-406fd48dd65b/small/logo-color-1-jpg.jpg https://www.healthindustrywatch.com/article/905470800-palvella-therapeutics-appoints-john-d-doux-m-d-m-b-a-dermatologist-and-recognized-leader-in-rare-skin-diseases-to-board-of-directors Health Industry Watch en PressRelease 2026-04-13T11:30:00+00:00 Palvella Therapeutics Appoints John D. Doux, M.D., M.B.A., Dermatologist and Recognized Leader in Rare Skin Diseases, to Board of Directors https://ml.globenewswire.com/media/83fd569b-5e6c-46ad-882a-6430f8ab755a/small/palvella-2025-logo-new-jpg.jpg https://www.healthindustrywatch.com/article/905470793-gelatide-drops-investigated-2026-report-what-consumers-should-verify-before-buying Health Industry Watch en PressRelease 2026-04-13T11:23:50+00:00 Gelatide Drops Investigated (2026 Report) What Consumers Should Verify Before Buying https://ml.globenewswire.com/Resource/Download/984a2986-fdd3-4fe6-80f2-312f9d1cbc94/image2.png https://www.healthindustrywatch.com/article/905467090-from-milestone-to-momentum-kraig-biocraft-leadership-travels-to-south-east-asia-following-record-setting-1-3-metric-ton-recombinant-spider-silk Health Industry Watch en PressRelease 2026-04-13T11:05:00+00:00 From Milestone to Momentum: Kraig Biocraft Leadership Travels to South East Asia Following Record-Setting 1.3 Metric Ton Recombinant Spider Silk Cocoon Production Cycle https://ml.globenewswire.com/media/3cf5ab91-0822-460b-bb13-17447941c84a/small/kblb-logo-jpg.jpg https://www.healthindustrywatch.com/article/905466754-oxb-launches-fast-track-offering-for-aav-and-lentiviral-vector-platforms-accelerating-viral-vector-development-and-manufacture Health Industry Watch en PressRelease 2026-04-13T11:00:00+00:00 OXB launches fast-track offering for AAV and lentiviral vector platforms, accelerating viral vector development and manufacture https://ml-eu.globenewswire.com/media/3e905c0a-b28c-4981-ac57-745647779ad9/small/oxb-new-logo-png.png https://www.healthindustrywatch.com/article/905466795-eclipse-life-sciences-completes-enrollment-in-phase-2-study-evaluating-ec-104-for-diabetic-macular-edema-dme Health Industry Watch en PressRelease 2026-04-13T11:00:00+00:00 Eclipse Life Sciences Completes Enrollment in Phase 2 Study Evaluating EC-104 for Diabetic Macular Edema (DME) https://ml.globenewswire.com/media/3ed9dd28-ed00-4f7d-b5b9-1180c2c99262/small/eclipse-logo-png.png https://www.healthindustrywatch.com/article/905466931-soleo-health-opens-new-ambulatory-infusion-center-in-louisville-kentucky Health Industry Watch en PressRelease 2026-04-13T11:00:00+00:00 Soleo Health Opens New Ambulatory Infusion Center in Louisville, Kentucky https://ml.globenewswire.com/media/b3c4bcdc-fa25-4f50-8b81-09f13e80a008/small/soleo-logo-1024-x-1024-png.png https://www.healthindustrywatch.com/article/905466947-nrx-pharmaceuticals-nasdaq-nrxp-announces-appointment-of-glenn-tyson-as-the-company-s-first-chief-commercial-officer Health Industry Watch en PressRelease 2026-04-13T11:00:00+00:00 NRx Pharmaceuticals (Nasdaq:NRXP) Announces Appointment of Glenn Tyson as the Company’s first Chief Commercial Officer https://ml.globenewswire.com/media/d879f1ff-d5d7-48d7-9731-c881b469d873/small/nrx-logo-300dpi-png.png https://www.healthindustrywatch.com/article/905466972-kymera-therapeutics-announces-u-s-fda-fast-track-designation-for-kt-621-a-first-in-class-oral-stat6-degrader-for-the-treatment-of-moderate-to Health Industry Watch en PressRelease 2026-04-13T11:00:00+00:00 Kymera Therapeutics Announces U.S. FDA Fast Track Designation for KT-621, a First-in-Class, Oral STAT6 Degrader for the Treatment of Moderate to Severe Asthma https://ml.globenewswire.com/media/4d3d3283-c57d-401e-9e1b-53f17e22d76b/small/kymera-logo-rgb-denim-marigold-high-res-png.png https://www.healthindustrywatch.com/article/905466973-spyre-announces-potential-best-in-class-spy001-part-a-induction-results-from-skyline-trial-in-moderate-to-severe-ulcerative-colitis-patients Health Industry Watch en PressRelease 2026-04-13T11:00:00+00:00 Spyre Announces Potential Best-in-Class SPY001 Part A Induction Results from SKYLINE Trial in Moderate-to-Severe Ulcerative Colitis Patients https://ml.globenewswire.com/media/bc26a912-b583-43c6-8423-55a4ba2bf4bd/small/spyre-logo-horizontal-full-color-rgb-583px-300ppi-jpg.jpg https://www.healthindustrywatch.com/article/905466986-ocular-therapeutix-announces-additional-positive-week-52-data-from-landmark-sol-1-phase-3-trial-of-axpaxli-in-wet-amd Health Industry Watch en PressRelease 2026-04-13T11:00:00+00:00 Ocular Therapeutix™ Announces Additional Positive Week 52 Data from Landmark SOL-1 Phase 3 Trial of AXPAXLI™ in Wet AMD https://ml.globenewswire.com/media/20ee0f50-7288-4f81-8546-f2ad2050ddbf/small/ocul-logo-jpg.jpg https://www.healthindustrywatch.com/article/905467081-imagenebio-announces-30-million-private-placement Health Industry Watch en PressRelease 2026-04-13T11:00:00+00:00 ImageneBio Announces $30 Million Private Placement https://ml.globenewswire.com/media/ccccc30d-a51c-48d7-9aec-6b542240c611/small/imagene-logo-green-jpg.jpg https://www.healthindustrywatch.com/article/905466794-ani-pharmaceuticals-announces-the-launch-of-carbamazepine-extended-release-capsules Health Industry Watch en PressRelease 2026-04-13T10:50:00+00:00 ANI Pharmaceuticals Announces the Launch of Carbamazepine Extended-Release Capsules https://ml.globenewswire.com/media/24d1d851-9075-4d6e-b22c-0c23a5ef0b36/small/ani-logo-png.png https://www.healthindustrywatch.com/article/905467025-leanzene-gummies-examined-2026-consumer-focused-breakdown-of-ingredients-claims-label-transparency Health Industry Watch en PressRelease 2026-04-13T10:47:40+00:00 Leanzene Gummies Examined: 2026 Consumer-Focused Breakdown of Ingredients, Claims & Label Transparency https://ml.globenewswire.com/Resource/Download/e7b8402e-d943-467a-8865-1fec7f5629cc/image2.png https://www.healthindustrywatch.com/article/905463063-regeneron-and-telix-announce-strategic-radiopharma-collaboration Health Industry Watch en PressRelease 2026-04-13T10:30:00+00:00 Regeneron and Telix Announce Strategic Radiopharma Collaboration https://ml.globenewswire.com/media/add5ebc7-88c9-49dc-8834-abbb07c622d1/small/regeneron-logo-jpg.jpg https://www.healthindustrywatch.com/article/905463143-telix-and-regeneron-announce-strategic-radiopharma-collaboration Health Industry Watch en PressRelease 2026-04-13T10:30:00+00:00 Telix and Regeneron Announce Strategic Radiopharma Collaboration https://ml.globenewswire.com/media/77ceffdf-31cc-415f-9747-efee950af329/small/telix-main-logo-3-png.png https://www.healthindustrywatch.com/article/904824600-derama-singapore-announces-ambassador-opportunity-for-its-luxury-postnatal-experience Health Industry Watch en PressRelease 2026-04-12T22:00:00+00:00 DeRAMA Singapore Announces Ambassador Opportunity for Its Luxury Postnatal Experience https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24828253-artyzen-hotel-exterior-1280x853.jpeg https://www.healthindustrywatch.com/article/905459654-prosomnus-receives-fda-class-ii-clearance-for-rpmo2-osa-device Health Industry Watch en PressRelease 2026-04-13T10:00:00+00:00 ProSomnus® Receives FDA Class II Clearance for RPMO2 OSA Device https://ml.globenewswire.com/media/333d9b0e-92b8-4e8b-ab32-6689f4113578/medium/prosomnus-rpmo2-osa-device-system.jpg https://www.healthindustrywatch.com/article/905451931-smart-minimalism-supreme-efficiency-cuktech-15-charging-station-makes-its-debut-in-malaysia Health Industry Watch en PressRelease 2026-04-13T08:40:54+00:00 Smart Minimalism, Supreme Efficiency: CUKTECH 15 Charging Station Makes Its Debut in Malaysia https://ml.globenewswire.com/media/3bf1f045-1f83-4d75-a8c5-1e9f3623347a/medium/image-1.png https://www.healthindustrywatch.com/article/905452017-berikut-adalah-terjemahan-siaran-akhbar-tersebut-ke-dalam-bahasa-melayu-minimalisme-pintar-kecekapan-ulung-stesen-pengecasan-cuktech-15-membuat Health Industry Watch en PressRelease 2026-04-13T08:40:54+00:00 Berikut adalah terjemahan siaran akhbar tersebut ke dalam Bahasa Melayu: Minimalisme Pintar, Kecekapan Ulung: Stesen Pengecasan CUKTECH 15 Membuat Kemunculan Sulung di Malaysia https://ml.globenewswire.com/media/3bf1f045-1f83-4d75-a8c5-1e9f3623347a/medium/image-1.png https://www.healthindustrywatch.com/article/905445010-epitopea-strengthens-scientific-advisory-board-with-appointment-of-leading-authority-in-cancer-lisa-butterfield Health Industry Watch en PressRelease 2026-04-13T08:00:00+00:00 Epitopea Strengthens Scientific Advisory Board with Appointment of Leading Authority in Cancer, Lisa Butterfield https://ml.globenewswire.com/media/e42e44d9-eec5-4ff3-a9ee-fab395efd2a8/small/epitopea-instagram-post-2-jpg.jpg https://www.healthindustrywatch.com/article/905445013-epitopea-renforce-son-comit-consultatif-scientifique-avec-la-nomination-de-lisa-butterfield-figure-de-renom-dans-le-domaine-du-cancer Health Industry Watch en PressRelease 2026-04-13T08:00:00+00:00 Epitopea renforce son comité consultatif scientifique avec la nomination de Lisa Butterfield, figure de renom dans le domaine du cancer https://ml.globenewswire.com/media/e42e44d9-eec5-4ff3-a9ee-fab395efd2a8/small/epitopea-instagram-post-2-jpg.jpg https://www.healthindustrywatch.com/article/905445007-boehringer-ingelheim-introduces-lenzelta-a-new-vaccine-advancing-mastitis-prevention-in-dairy-cows Health Industry Watch en PressRelease 2026-04-13T07:51:00+00:00 Boehringer Ingelheim introduces LENZELTA®: A new vaccine advancing mastitis prevention in dairy cows https://ml-eu.globenewswire.com/media/f121dfae-77e7-4a01-b1ef-6b757767ddab/small/111boehringer-ingelheim-logo-rgb-dark-green-002-png.png https://www.healthindustrywatch.com/article/905445021-rising-uk-dental-costs-and-nhs-access-crisis-drive-record-demand-for-treatment-in-t-rkiye-dentspa-leads-the-response Health Industry Watch en PressRelease 2026-04-13T07:30:00+00:00 Rising UK Dental Costs and NHS Access Crisis Drive Record Demand for Treatment in Türkiye — DentSpa Leads the Response https://ml-eu.globenewswire.com/media/53fb3ee2-7271-4c5f-b8b5-f4e6db89cc89/small/dentspa-logo-blue-png.png https://www.healthindustrywatch.com/article/905432318-synox-therapeutics-announces-positive-topline-results-from-the-phase-3-tangent-study-supporting-emactuzumab-as-a-differentiated-next-generation Health Industry Watch en PressRelease 2026-04-13T06:00:00+00:00 SynOx Therapeutics Announces Positive Topline Results from the Phase 3 TANGENT Study, Supporting Emactuzumab as a Differentiated, Next-generation Treatment for Patients with Tenosynovial Giant Cell Tumor (TGCT) https://ml.globenewswire.com/media/35d87dbe-62e3-4299-9eba-3ccdbea5d85e/small/synox-logo-jpg.jpg https://www.healthindustrywatch.com/article/905424235-press-release-sanofi-and-regeneron-s-dupixent-approved-in-the-eu-as-the-first-targeted-medicine-to-treat-young-children-with-chronic-spontaneous Health Industry Watch en PressRelease 2026-04-13T05:00:00+00:00 Press Release: Sanofi and Regeneron’s Dupixent approved in the EU as the first targeted medicine to treat young children with chronic spontaneous urticaria https://ml-eu.globenewswire.com/media/06da731a-67a1-4258-939f-6ef0531ee3bf/small/sanofi-new-logo-jpg.jpg https://www.healthindustrywatch.com/article/905424236-communiqu-de-presse-dupixent-de-sanofi-et-regeneron-approuv-dans-l-ue-comme-premier-m-dicament-cibl-contre-l-urticaire-chronique-spontan-e-chez Health Industry Watch en PressRelease 2026-04-13T05:00:00+00:00 Communiqué de presse : Dupixent de Sanofi et Regeneron approuvé dans l'UE comme premier médicament ciblé contre l'urticaire chronique spontanée chez les jeunes enfants https://ml-eu.globenewswire.com/media/06da731a-67a1-4258-939f-6ef0531ee3bf/small/sanofi-new-logo-jpg.jpg https://www.healthindustrywatch.com/article/905424246-data-published-in-nature-communications-highlights-unique-mechanism-of-action-of-alpibectir-in-combination-with-ethionamide-alpe Health Industry Watch en PressRelease 2026-04-13T05:00:00+00:00 Data Published in Nature Communications Highlights Unique Mechanism of Action of Alpibectir in Combination with Ethionamide (AlpE) https://ml.globenewswire.com/media/37dee549-5eb0-418f-a16c-11d8422babfb/small/logo-bioversys-color-rgb-neu-for-prs-jpg.jpg https://www.healthindustrywatch.com/article/905424249-dupixent-dupilumab-approved-in-the-eu-as-the-first-targeted-medicine-to-treat-young-children-with-chronic-spontaneous-urticaria-csu Health Industry Watch en PressRelease 2026-04-13T05:00:00+00:00 Dupixent® (dupilumab) Approved in the EU as the First Targeted Medicine to Treat Young Children with Chronic Spontaneous Urticaria (CSU) https://ml.globenewswire.com/media/add5ebc7-88c9-49dc-8834-abbb07c622d1/small/regeneron-logo-jpg.jpg https://www.healthindustrywatch.com/article/904304424-village-green-enhances-dementia-care-with-new-service-expansion Health Industry Watch en PressRelease 2026-04-12T14:00:00+00:00 Village Green Enhances Dementia Care with New Service Expansion https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24827500-memory-care-facility-in-spring-1024x768.jpeg https://www.healthindustrywatch.com/article/905385512-nxera-pharma-s-partner-neurocrine-biosciences-doses-first-patient-in-phase-2-trial-of-nbi-1117570-for-adults-with-schizophrenia Health Industry Watch en PressRelease 2026-04-12T23:30:00+00:00 Nxera Pharma’s Partner Neurocrine Biosciences Doses First Patient in Phase 2 Trial of NBI-1117570 for Adults with Schizophrenia https://ml-eu.globenewswire.com/media/5cc74d52-c86f-4e21-8684-3496281fee15/small/nxera-master-logo-rgb-black-1-png.png https://www.healthindustrywatch.com/article/905280126-tairex-launches-virtual-consultation-room-setting-a-new-paradigm-for-ai-medical-services Health Industry Watch en PressRelease 2026-04-12T10:32:59+00:00 Tairex Launches Virtual Consultation Room, Setting A New Paradigm for AI Medical Services https://www.healthindustrywatch.com/article/905193031-american-board-of-nursing-artificial-intelligence-announces-national-competency-framework-and-certification-pathway Health Industry Watch en PressRelease 2026-04-12T10:00:09+00:00 American Board of Nursing Artificial Intelligence Announces National Competency Framework and Certification Pathway https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24830787-abnai-1280x720.png https://www.healthindustrywatch.com/article/905363129-scrap-the-ban-keep-the-controls-caphra-s-message-to-bangladesh Health Industry Watch en PressRelease 2026-04-12T20:56:25+00:00 Scrap the Ban, Keep the Controls: CAPHRA's Message to Bangladesh https://ml.globenewswire.com/media/6dc95f2d-65fb-409f-aed4-9ebe55554004/small/picture1-png.png https://www.healthindustrywatch.com/article/904463088-beyond-the-therapy-hour-onwardwell-brings-holistic-sex-addiction-support-to-connecticut-families Health Industry Watch en PressRelease 2026-04-11T19:11:43+00:00 Beyond the Therapy Hour: OnwardWell Brings Holistic Sex Addiction Support to Connecticut Families https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24828353-onwardwell-logo-355x134.jpeg https://www.healthindustrywatch.com/article/905151803-4life-awards-inaugural-lawrence-prize Health Industry Watch en PressRelease 2026-04-11T18:31:25+00:00 4Life Awards Inaugural Lawrence Prize https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24830751-medal-1-800x618.jpeg https://www.healthindustrywatch.com/article/904948804-results-diagnostics-expands-specialized-lab-services-for-behavioral-health-and-sud-facilities-nationwide Health Industry Watch en PressRelease 2026-04-11T17:17:46+00:00 Results Diagnostics Expands Specialized Lab Services for Behavioral Health and SUD Facilities Nationwide https://www.healthindustrywatch.com/article/904975261-national-board-of-executive-function-certification-adds-trauma-credential Health Industry Watch en PressRelease 2026-04-11T16:51:37+00:00 National Board of Executive Function Certification Adds Trauma Credential https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24830543-national-board-of-executive-fun-500x500.png https://www.healthindustrywatch.com/article/904762514-spring-ready-legs-akribis-veins-vitality-encourages-early-treatment-for-spider-and-varicose-veins Health Industry Watch en PressRelease 2026-04-11T15:30:00+00:00 Spring Ready Legs: Akribis Veins & Vitality Encourages Early Treatment for Spider and Varicose Veins https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24829766-laser-vein-treatment-1333x2000.jpeg https://www.healthindustrywatch.com/article/905140755-upcoming-national-women-s-health-week-promoting-scalp-care-and-breathable-wig-solutions Health Industry Watch en PressRelease 2026-04-11T14:00:00+00:00 Upcoming National Women’s Health Week: Promoting Scalp Care and Breathable Wig Solutions https://ml.globenewswire.com/media/OTI3YTJhY2UtNjYzMS00YWRhLWE4MTgtYTNmYTI2NWY1Yjg5LTEzMTk4MDUtMjAyNi0wNC0xMS1lbg==/tiny/Klaiyi-Hair.png